COGENT BIOSCIENCES INC (COGT) Stock Income Statement
NASDAQ:COGT - Nasdaq - US19240Q2012 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 7.87M | 22.50M | |||
| Operating Expenses | 208.13M | 147.84M | 75.55M | 90.07M | 54.68M | |||
| Research and Development | 173.75M | 121.63M | 55.91M | 72.65M | 43.71M | |||
| Selling, General, and Administrative Expenses | 34.38M | 26.21M | 19.64M | 17.42M | 10.97M | |||
| Operating Income | -208.13M | -147.84M | -75.55M | -82.20M | -32.18M | |||
| Interest Income/Expense | 13.08M | 3.99M | 470.00K | 140.00K | 270.00K | |||
| Other Income/Expense | 2.64M | 4.01M | 2.81M | -250.00K | 80.00K | |||
| Non Recurring Items | N/A | -400.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -192.41M | -140.24M | -72.27M | -74.81M | -31.83M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -192.41M | -140.24M | -72.27M | -179.21M | -31.83M | |||
| EBITDA | -205.86M | -147.00M | -75.40M | -81.48M | -30.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.42 | -2.39 | -1.87 | -16.17 | -4.18 | |||
| Non GAAP EPS | -2.40 | -2.45 | -1.85 | -8.10 | -4.20 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -2277.13% | -141.47% | |||
| Operating Profit Margin | N/A | N/A | N/A | -1044.47% | -143.02% | |||
All data in USD